Seroincidence of SARS-CoV-2 IgG Antibodies and Risk Factors in Asymptomatic Health Care Workers at the Villavicencio Departmental Hospital
DOI:
https://doi.org/10.17533/udea.rfnsp.e346034Keywords:
Coronavirus disease 2019 (COVID-19), immunoglobulin type G (IgG), pandemic, severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), Indirect ELISA.Abstract
Objective: To estimate the cumulative seroincidence of anti-sars-CoV-2 immunoglobulin (Ig) class G (IgG) in asymptomatic health care workers and its epidemiological association within the functional areas of the Villavicencio Departmental Hospital (HDV).
Methodology: A longitudinal analytical observational study of a cohort of workers was conducted in which anti-SARS-CoV-2 IgG levels in blood serum were measured every 21 days on three occasions using an indirect ELISA in a random representative sample (n = 105) of hospital health workers (N = 756). The data collection tool was a survey in which each healthcare worker indicated that they had not been diagnosed with COVID-19 and provided information on the independent variables: sex, age, job status, functional area, and comorbidities.
Results: The baseline prevalence for SARS-CoV-2 among asymptomatic HDV healthcare workers was 9.52% (CI 95% 5.25-16.65). Cumulative seroincidence over 42 days was 12.38% (CI 95% 7.38-20.04). Relative risk (RR) was used to establish the risk factors associated with the independent variables. Male sex (adjusted RR 3.34, CI 95% 1.98-5.86), obesity (adjusted RR 10.98, CI 95% 1.41-85.98) and female sex (adjusted RR 2.15, CI 95% 1.12-4.31) in the functional areas of Hospitalization, Critical Medicine and Emergency, respectively, are risk factors in the HDV.
Conclusion: During 42 days of epidemiological follow-up, 13 out of 105 hospital healthcare workers seroconverted positively for SARS-CoV-2 and remained asymptomatic. Additionally, significant risk factors are associated with their exposure to this virus in the HDV.
Downloads
References
Phan T. Novel coronavirus: From discovery to clinical diagnostics. Infect Genet Evol. 2020;79:104211. doi: https://doi.org/10.1016/j.meegid.2020.104211
World Health Organization. who Director-General’s opening remarks at the media briefing on covid-19 - 11 March 2020 [internet]. 2020 [citado 2021 ene. 21]. Disponible en: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020;382:1708-20. doi: https://doi.org/10.1056/nejmoa2002032
Mizumoto K, Kagaya K, et al. Estimating the asymptomatic proportion of coronavirus disease 2019 (covid-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan. Euro Surveill. 2020;25(10):2000180. doi: https://doi.org/10.2807/1560-7917.ES.2020.25.10.2000180
Garcia-Basteiro A, Moncunill G, Tortajada M, et al. Seroprevalence of antibodies against sars-CoV-2 among health care workers in a large Spanish reference hospital. Nat Commun. [internet]. 2020 [citado 2021 mar. 20]; 11;3500. doi: https://doi.org/10.1038/s41467-020-17318-x
Long Q, Tang X, Shi Q, et al. Clinical and immunological assessment of asymptomatic sars-CoV-2 infections. Nat Med. 2020;26:1200-4. doi: https://doi.org/10.1038/s41591-020-0965-6
Oran D, Topol E. Prevalence of asymptomatic sars-CoV-2 infection. Ann Intern Med. 2020;173(5):362-7. doi: https://doi.org/10.7326/M20-3012
Gudbjartsson D, Helgason A, Jonsson H, al. Spread of sars-CoV-2 in the Icelandic population. N Engl J Med. [internet]. 2020 [citado 2021 ene. 21]; 382:2302-15. doi: https://doi.org/10.1056/NEJMoa2006100
Ing A, Cocks C, Green J. covid-19: In the footsteps of Ernest Shackleton. Thorax. 2020;75(8):693-4. doi: http://dx.doi.org/10.1136/thoraxjnl-2020-215091
Instituto Nacional de Salud. Bogotá: covid-19 en personal de salud en Colombia. Boletín. 2021 [internet]; (92) [citado 2021 may. 27]. Disponible en: https://www.ins.gov.co/Noticias/Paginas/coronavirus-personal-salud.aspx
Chen Y, Tong X, Jian Wang J, et al. High sars-CoV-2 antibody prevalence among healthcare workers exposed to covid-19 patients. J Infect. 2020;81(3):420-6. doi: https://doi.org/10.1016/j.jinf.2020.05.067
Rivett L, Sridhar S, Sparkes D, et al. Screening of healthcare workers for sars-CoV-2 highlights the role of asymptomatic carriage in covid-transmission. eLife. [internet]. 2020 [citado 2021 mar. 15]; 9:e58728. doi: https://doi.org/10.7554/eLife.58728
Franco M, Ariza B, Torres T, et al. Seroprevalence and seroconversion rates to sars-CoV-2 in interns, residents, and medical doctors in a University Hospital in Bogotá, Colombia. Infectio. 2021;25(3):145-52. doi: http://dx.doi.org/10.22354/in.v25i3.938
Instituto Nacional de Salud de Colombia y Grupo Colaborativo Estudio País. Seroprevalencia de sars-CoV-2 durante la epidemia en Colombia: estudio país. Reporte preliminar No. 2. Resultados globales Leticia, Barranquilla, Medellín, Bucaramanga, Cúcuta, Villavicencio, Cali, Bogotá, Ipiales, Guapí [internet]. 2020 [citado 2021 may. 27]. Disponible en: https://www.ins.gov.co/BibliotecaDigital/Seroprevalencia-Colombia-reporte-preliminar-n-2.pdf
Centros para el Control y la Prevención de Enfermedades cdc. Atlanta: Epi InfoTM. [internet]; 2019 [citado 2021 may. 27]. Disponible en: https://www.cdc.gov/epiinfo/esp/es_index.html
Creative Diagnostics®. sars-CoV-2 elisa Kit (deiasl019) [internet]; s. f. [citado 2021 may. 27]. Disponible en: http://img2.creative-diagnostics.com/pdf/DEIASL019.pdf
Asociación Médica Mundial [internet]. Ferney-Voltaire. Declaración de Helsinki de la amm – Principios éticos para las investigaciones médicas en seres humanos [internet]; 2017 [citado 2021 may. 27]. Disponible en: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/
Colombia, Ministerio de Salud. Resolución 008430, por la cual se establecen las normas científicas, técnicas y administrativas para la administración en salud (1993 octubre 4).
Zhao J, Yuan Q, Wang H, et al. Antibody responses to sars-CoV-2 in patients with novel coronavirus disease 2019. Clin Infect Dis. 2020;71(16):2027-34. doi: https://doi.org/10.1093/cid/ciaa344
Guo L, Ren L, Yang S, et al. Profiling early humoral response to diagnose novel coronavirus disease (covid-19). Clin Infect Dis. 2020;71(15):778-85. doi: https://doi.org/10.1093/cid/ciaa310
Milani G, Dioni L, Favero C, et al. Serological follow-up of sars-CoV-2 asymptomatic subjects. Sci Rep. 2020;10:20048. doi: https://doi.org/10.1038/s41598-020-77125-8
Dan J, Mateus J, Kato Y, et al. Immunological memory to sars-CoV-2 assessed for up to 8 months after infection. Science. 2021;371(6529):eabf4063. doi: https://doi.org/10.1126/science.abf4063
Pallett S, Rayment M, Patel A, et al. Point-of-care serological assays for delayed sars-CoV-2 case identification among health-care workers in the uk: A prospective multicentre cohort study. Lancet Respir Med. 2020;8(9):885-94. doi: https://doi.org/10.1016/S2213-2600(20)30315-5
Shields A, Faustini S, Perez-Toledo M, et al. sars-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: A cross-sectional study. Thorax. [internet]. 2020 [citado 2021 feb. 22]; 75(12):1089-94. doi: https://doi.org/10.1136/thoraxjnl-2020-215414
Lumley S, O’Donnell D, Stoesser N, et al. Antibody status and incidence of sars-CoV-2 infection in health care workers. N Engl J Med. 2021;384(5):533-40. doi: https://doi.org/10.1056/NEJMoa2034545
Instituto Nacional de Salud. Bogotá: covid-19 en Colombia. Distribución de casos por departamento [internet]; 2021 [citado 2021 may. 27]. Disponible en: https://www.ins.gov.co/Noticias/Paginas/coronavirus-departamento.aspx
Schneider S, Piening B, Nouri-Pasovsky P, et al. sars-Coronavirus-2 cases in healthcare workers may not regularly originate from patient care: Lessons from a university hospital on the underestimated risk of healthcare worker to healthcare worker transmission. Antimicrob Resist Infect Control. [internet]. 2020 [citado 2021 mar. 08]; 9;192. doi: https://doi.org/10.1186/s13756-020-00848-w
Schwierzeck V, Correa‐Martinez C, Schneider K, et al. sars‐CoV‐2 in the employees of a large university hospital. Dtsch Arztebl Int. 2020;117(19):344-5. doi: https://doi.org/10.3238/arztebl.2020.0344
Rudberg A, Havervall S, Månberg A, et al. sars-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun. [internet]. 2020 [citado 2021 mar. 20]; 11:5064. doi: https://doi.org/10.1038/s41467-020-18848-0
Zhang S, Guo M, Wu F, et al. Factors associated with asymptomatic infection in health-care workers with severe acute respiratory syndrome coronavirus 2 infection in Wuhan, China: A multicentre retrospective cohort study. Clinical Microb Infect. 2020;26(12):1670-5. doi: https://doi.org/10.1016/j.cmi.2020.08.038
Yang L, Li-Meng Y, Lagen W, et al. Viral dynamics in mild and severe cases of covid-19. The Lancet Infect Dis. 2020;20(6):656-7. doi: https://doi.org/10.1016/S1473-3099(20)30232-2
Michalakis K, Ilias I. sars-CoV-2 infection and obesity: Common inflammatory and metabolic aspects. Diabetes Metab Syndr. 2020;14(4):469-71. doi: https://doi.org/10.1016/j.dsx.2020.04.033
Vahidy F, Pan A, Ahnstedt H, et al. Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse us metropolitan area. plos one [internet]. 2021 [citado 2021 abr. 15]; 16(1):e0245556. doi: https://doi.org/10.1371/journal.pone.0245556
Zeng F, Dai C, Cai P, et al. A comparison study of sars‐CoV‐2 IgG antibody between male and female covid‐19 patients: A possible reason underlying different outcome between sex. J Med Virol. 2020;92(10):2050-4. doi: https://doi.org/10.1002/jmv.25989
Subramanian A, Anand A, Adderley N, et al. Increased covid-19 infections in women with polycystic ovary syndrome: A population-based study. Eur. J. Endocrinol. 2021;184(5):637-45. doi: https://doi.org/10.1530/EJE-20-1163
Moazzami B, Chaichian S, Samie S, et al. Does endometriosis increase susceptibility to covid-19 infections? A case–control study in women of reproductive age. bmc Women’s Health. 2021;21,119. doi: https://doi.org/10.1186/s12905-021-01270-z
Pivonello R, Auriemma R, Pivonello C, et al. Sex disparities in covid-19 severity and outcome: Are men weaker or women stronger? Neuroendocrinology [internet]. 2020 [citado 2021 may. 28]; 1-20. doi: https://doi.org/10.1159/000513346
Reynolds C, Swadling L, Gibbons J, et al. Discordant neutralizing antibody and T cell responses in asymptomatic and mild sars-CoV-2 infection. Sci. Immunol [internet]. 2020 [citado 2021 abr. 16]; 5(54):eabf3698. doi: https://immunology.sciencemag.org/content/5/54/eabf3698
Published
How to Cite
License
Copyright (c) 2022 Universidad de Antioquia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The contents of the articles are the responsibility of the authors
The editorial committee has editorial independence from the National School of Public Health "Héctor Abad Gómez" of the University of Antioquia.
The editorial committee is not responsible for aspects related to copying, plagiarism or fraud that may appear in the articles published in it.
When you are going to reproduce and disclose photographs or personal data in printed or digital format, informed consent is required. Therefore, this requirement is required of the author at the time of receipt of the manuscript.
Authors are responsible for obtaining the necessary permissions to reproduce any material protected by reproduction rights.
The authors preserve the moral rights and assign the economic rights that will correspond to the University of Antioquia, to publish it, distribute electronic copies, include them in indexing services, directories or national and international databases in Open Access, under the Creative Commons Attribution license -Not Commercial-Share Equal 4.0 International Commercial (CC BY-NC-SA) which allows others to distribute, remix, retouch, and create from the work in a non-commercial way, as long as the respective credit and license are granted. new creations under the same conditions.
The authors will sign the declaration of transfer of economic rights to the University of Antioquia, after the acceptance of the manuscript.
The editorial committee reserves the right to reject the articles whose authors do not offer satisfactory explanations about the contribution of each author, to meet the criteria of authorship in the submission letter. All authors must meet the four criteria of authorship according to ICMJE: "a) .- That there is a substantial contribution to the conception or design of the article or to the acquisition, analysis or interpretation of the data. b) That they have participated in the design of the research work or in the critical review of its intellectual content. c) .- That has been intervened in the approval of the final version that will be published.d). That they have the capacity to respond to all aspects of the article in order to ensure that issues related to the accuracy or integrity of any part of the work are adequately investigated and resolved. "
-- 
--
